Navigation Links
Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
Date:10/31/2011

Avastin®, an antibody that blocks the activity of VEGF-A, clinically validated anti-angiogenic drugs as an effective means of inhibiting solid tumour growth. By blocking the interaction of VEGF-A with its receptors, primarily VEGFR-2, the multi-billion dollar cancer therapeutic slows tumour growth by inhibiting blood vessel recruitment into the tumour, effectively starving tumours of essential nutrients and oxygen required for growth. However after a short period of time tumors can begin to grow again in the presence of Avastin® . Avastin® is approved by the US FDA in the following indications: metastatic colorectal cancer, non-squamous-cell lung cancer, metastatic breast cancer, glioblastoma, and metastatic renal cell carcinoma.

The angiogenic receptor VEGFR-2 can also be stimulated by VEGF-C and hence an inhibitor such as VGX-100, a key therapeutic in Circadian's portfolio, can produce greater blockade of this receptor pathway. As such, VGX-100 has the potential to block blood vessel growth in tumours which grow in the presence of Avastin® therapy and hence may completely shut down angiogenesis (the growth of blood vessels) mediated by VEGFR-2.

VEGF-C along with the molecule VEGF-D are also the only known proteins to bind and activate VEGFR-3 which drives lymphatic vessel and tumour-associated blood vessel growth. Inhibitors of VEGF-C thus have therapeutic potential to inhibit not only primary tumour growth through their anti-angiogenic activities, but to also inhibit tumour spread or metastasis via the lymphatic vessels - a mechanism of tumour dissemination that is often the deadliest aspect of many tumour types and a mechanism that is not effectively blocked by anti-VEGF-A or anti-VEGFR-2 therapeutics.

Inherent risks of Investment in Biotechnology Companies There are a number of inherent risks associated with the development of pharmaceutical products to a marketable stage. The lengthy clinical trial process is desi
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Cyberonics Receives FDA Approval for Expansion of MRI Use With VNS Therapy® Systems
4. Mylan Receives Approval for Generic Version of MS Contin® Tablets
5. SAFC Verona HPAPI Manufacturing Facility Receives SafeBridge Certification
6. INNOPHARMA Receives FDA Approval of Generic Olanzapine Injection
7. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
8. Neuralstem Receives FDA Approval to Dose Patients in Cervical Region in Ongoing ALS Trial
9. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
10. Boca Pharmacal Receives FDA Approval on Glycopyrrolate Tablets
11. Institute of Health Sciences Receives ABHES Institutional Accreditation for Long Distance Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Syneron Medical Ltd. (NASDAQ: ELOS ), a leading ... three month period ended June 30, 2015. ... Highlights: , Revenue of $73.5 million, up ... American product sales grew 45% year-over-year. , International sales ... product growth in the EMEA region and 25% product growth ...
(Date:8/3/2015)... 3, 2015  Luminex Corporation (NASDAQ: LMNX ) ... June 30, 2015.  Financial and operating highlights for the ... quarter 2015 revenue by 6 percent to $58.9 million, ... second quarter 2015 assay revenue by 22 percent to ... 2014. , Increased Q2 2015 royalty revenue by ...
(Date:8/3/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... quarter ended June 30, 2015. All comparisons, unless otherwise noted, ... Second Quarter 2015 Highlights include: , Revenue ... , Total prescriptions dispensed of 234,000, an increase of ... , Adjusted EBITDA of $22.7 million, an increase of 287% ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5
(Date:8/4/2015)... ... August 04, 2015 , ... ... at unique artistic expressions from a diverse group of exceptionally talented female artists. ... Music & Art Festival on September 25-27, 2015 in Downtown Las Vegas. Curated ...
(Date:8/4/2015)... ... August 04, 2015 , ... MedicaSoft ... Office of the National Coordinator for Health Information Technology (ONC-HIT) 2014 Edition ... highest quality personal health record and patient portal solution to healthcare providers ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... older brings an automatic end to driving, says the August 2015 Harvard Health ... is okay to drive. It requires an individual assessment of skills," says Lissa ...
(Date:8/4/2015)... ... August 04, 2015 , ... METTLER TOLEDO has announced an ... researchers from Lubrizol, Pfizer, and Merck. This free online seminar will be ... timelines often require informed decisions with limited process understanding. Established methods have ...
(Date:8/4/2015)... ... August 04, 2015 , ... Half of consumers are ... board-certified is increasingly influential in their choice of practitioner, according to new survey ... Survey on Cosmetic Dermatologic Procedures reflects overall consumer views on cosmetic medical treatments ...
Breaking Medicine News(10 mins):Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4
... -- The American College of Physicians (ACP) has received a ... of a patient-centered medical home (PCMH). The grant, part ... underwrite a 10-month study which began in November. ACP ... a conceptual model of care whose goal is to put ...
... 15 years, use of opioid medications to treat patients ... patients were more likely to receive opioids than patients ... the January 2 issue of JAMA. , In ... the problem of inadequately treated pain. Also, racial and ...
... January 1 issue of the journal SLEEP finds that ... cardiovascular responses during recovery from maximal exercise. These ... heart rate during recovery, and may be an early ... study, authored by Trent A. Hargens, PhD, of Virginia ...
... treat chronic and recurrent tonsillitis substantially improve a patients ... to two new studies published as a supplement to ... , In one study involving 72 adults, patients showed ... Adenoid Health Status Instrument (TAHSI), a scale used to ...
... ... Boards Merge, CANTON, Ohio, Dec. 31 Two county boards have,merged ... Alcohol and Drug Addiction Services Board of Stark County are,now a single ... "The combined Board will create a stronger advocate for people with,mental ...
... YORK, Dec. 31 The New Year ... finally lose those excess pounds in a ... to this report from GlaxoSmithKline at:, http://media.medialink.com/WebNR.aspx?story=34274 ... audio, text, graphics and,photos for free and ...
Cached Medicine News:Health News:American College of Physicians receives grant to study cost of patient-centered medical home 2Health News:Use of opioids for pain in ERs on the rise, but racial differences in use still exist 2Health News:Use of opioids for pain in ERs on the rise, but racial differences in use still exist 3Health News:Undiagnosed OSA patients have altered cardiovascular responses during exercise recovery 2Health News:Undiagnosed OSA patients have altered cardiovascular responses during exercise recovery 3Health News:Combined Boards Provide Better Care to More Clients More Efficiently 2
... just about everything imaginable that might have to ... is designed for long term storage under archival ... over metal systems is overlooked, while the natural ... of desiccator and insulator, providing an environment that ...
A prepared Microscope Slide Cataloging and Storage System....
... Our moisture resistant, plastic covered ... high, each supporting up to 500 ... weight. Each box accommodates 2000 slides ... your varied storage requirements. Come unassembled ...
Shandon Plastic Slide Boxes...
Medicine Products: